N. R. Sindhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
N. R. Sindhu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Ajit Sebastian
Department of Gynaecologic Oncology, Christian Medical College, Vellore, India
2 shared publications - Anitha Thomas
Department of Gynaecologic Oncology, Christian Medical College, Vellore, India
2 shared publications - Dhanya Susan Thomas
Department of Gynaecologic Oncology, Christian Medical College, Vellore, India
2 shared publications - Vinotha Thomas
Department of Gynaecologic Oncology, Christian Medical College, Vellore, India
2 shared publications - Abha Elizabeth John
Department of General Pathology, Christian Medical College, Vellore, India
1 shared publication - P. S. Raji
Department of Gynaecological Oncology, Christian Medical College, Vellore, India
1 shared publication
Latest Publications
- 29 August 2024
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 146-151
Risk of Gynaecological Cancers as Second Primary in Non-gynaecological Cancer Survivors: A Retrospective Cohort Study
This study aims to explore the clinical-pathological profile of gynaecological malignancies occurring as a second cancer and identify their modifiable and non-modifiable risk factors. This retrospective cohort study included women operated for gynaecological carcinoma following a previous treated malignancy, in the gynaecologic oncology department of a tertiary care hospital, between 1st January 2016 and 31st December 2021. Demographic details, clinical and pathological characteristics of the current malignancy and previous malignancy were obtained from medical records and analysed using descriptive statistics. During this period, 2370 women with gynaecological malignancies were operated, of whom 27 (1.1%) patients had gynaecological malignancy as a second malignancy. This included 19 (70.3%) endometrial and 8 (29.6%) ovarian cancer patients following a median period of 48 (24-144 months) from the index malignancy. Their median age and BMI were 60 years (37-67) and 27 (17-39.1), respectively. Endometrioid endometrial cancer was most common and was preceded by breast carcinoma in 19 (70.37%) and colorectal in 5 (18.5%). Four patients had previous microsatellite unstable colorectal cancer. Two patients were found to have mismatch repair deficient endometrial cancer on somatic testing. High-grade serous carcinoma was the most common ovarian histology and was preceded by breast cancer in 6 (75%). Four patients underwent germline testing, and one was found to have a (breast cancer gene) BRCA pathogenic mutation. Breast cancer and colon cancer can precede gynaecologic cancer. Individualization of somatic and genetic testing in colorectal and breast cancers will allow screening and prevention of second gynaecologic malignancies.
- 29 August 2024
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 75 (S1) , 146-151
Risk of Gynaecological Cancers as Second Primary in Non-gynaecological Cancer Survivors: A Retrospective Cohort Study
This study aims to explore the clinical-pathological profile of gynaecological malignancies occurring as a second cancer and identify their modifiable and non-modifiable risk factors. This retrospective cohort study included women operated for gynaecological carcinoma following a previous treated malignancy, in the gynaecologic oncology department of a tertiary care hospital, between 1st January 2016 and 31st December 2021. Demographic details, clinical and pathological characteristics of the current malignancy and previous malignancy were obtained from medical records and analysed using descriptive statistics. During this period, 2370 women with gynaecological malignancies were operated, of whom 27 (1.1%) patients had gynaecological malignancy as a second malignancy. This included 19 (70.3%) endometrial and 8 (29.6%) ovarian cancer patients following a median period of 48 (24-144 months) from the index malignancy. Their median age and BMI were 60 years (37-67) and 27 (17-39.1), respectively. Endometrioid endometrial cancer was most common and was preceded by breast carcinoma in 19 (70.37%) and colorectal in 5 (18.5%). Four patients had previous microsatellite unstable colorectal cancer. Two patients were found to have mismatch repair deficient endometrial cancer on somatic testing. High-grade serous carcinoma was the most common ovarian histology and was preceded by breast cancer in 6 (75%). Four patients underwent germline testing, and one was found to have a (breast cancer gene) BRCA pathogenic mutation. Breast cancer and colon cancer can precede gynaecologic cancer. Individualization of somatic and genetic testing in colorectal and breast cancers will allow screening and prevention of second gynaecologic malignancies.
- 19 August 2024
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (3) , 1-5
Giant Borderline Mucinous Cystadenoma: Hazards of Surgical Debulking
- 19 August 2024
- Published by Springer Nature in Indian Journal of Gynecologic Oncology
- Vol. 22 (3) , 1-5
Giant Borderline Mucinous Cystadenoma: Hazards of Surgical Debulking
- 28 January 2021
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- Vol. 10 (2) , 781-783
Choriocarcinoma presenting following a molar pregnancy and preterm vaginal delivery: rarest of rare case
Choriocarcinoma is the aggressive histologic type of GTN and is characterized by vascular invasion and metastases of widespread. Choriocarcinoma metastasizes hematogenously. Suction and evacuation were done on admission. Beta-hCG was 67900 mIU/ml and 144523 mIU/ml on day 1 and day 3 respectively and histopathology showed Choriocarcinoma. This is very unusual case of reviewing sequential events. It was difficult to detect is it new pregnancy or choriocarcinoma. Investigators were biased with high beta-hCG values indicating malignancy. So there was differential diagnosis as choriocarcinoma based on history of molar pregnancy and increasing beta-hCG value and also dictum of 'non molar pregnancy following live birth is always choriocarcinoma. However histopathology report suggested choriocarcinoma and was diagnostic.
- 28 January 2021
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- Vol. 10 (2) , 781-783
Choriocarcinoma presenting following a molar pregnancy and preterm vaginal delivery: rarest of rare case
Choriocarcinoma is the aggressive histologic type of GTN and is characterized by vascular invasion and metastases of widespread. Choriocarcinoma metastasizes hematogenously. Suction and evacuation were done on admission. Beta-hCG was 67900 mIU/ml and 144523 mIU/ml on day 1 and day 3 respectively and histopathology showed Choriocarcinoma. This is very unusual case of reviewing sequential events. It was difficult to detect is it new pregnancy or choriocarcinoma. Investigators were biased with high beta-hCG values indicating malignancy. So there was differential diagnosis as choriocarcinoma based on history of molar pregnancy and increasing beta-hCG value and also dictum of 'non molar pregnancy following live birth is always choriocarcinoma. However histopathology report suggested choriocarcinoma and was diagnostic.